Neuvivo’s investigational therapy NP001 (sodium chlorite), designed to dampen inflammation and restore immune system balance, extended survival in…
Articles by Steve Bryson, PhD
Researchers have developed a type of gene therapy that can rescue the function of the TDP-43 protein in diseased nerve…
Differences in tear metabolites — the products of metabolism that are found in human tears — in people with…
Researchers detected changes in the production of several immune signaling proteins, called cytokines, in the cerebrospinal fluid (CSF) — the…
A $22 million federal grant to the Mayo Clinic in Florida will fund a study providing access to the investigational…
A computer analysis using real-world data from an amyotrophic lateral sclerosis (ALS) clinic identified four groups of patients with…
A new genetic mutation that may cause amyotrophic lateral sclerosis (ALS) has been discovered in families living in La…
Io Therapeutics is planning to launch a Phase 2 trial into its investigational oral therapy IRX4204 in people…
Repeat infusions of naive immune B-cells were safe and delayed disease onset, reduced disease severity, and extended survival in animal…
The use of nonpharmacological treatment — interventions such as muscle exercise, aerobics, and strength training — did not significantly ease…